Is 22q11.2 Deletion Syndrome Hereditary?
At a Glance
While 22q11.2 deletion syndrome can be hereditary, about 90% of cases occur randomly (de novo) and are not passed down from a parent. If a parent has the deletion, there is a 50% chance of passing it to their child. If neither parent has it, the recurrence risk is about 1%.
The short answer is yes, 22q11.2 deletion syndrome can be hereditary, but the vast majority of cases are not passed down from a parent. In about 90% of people diagnosed with the condition, the deletion occurs de novo [1]. De novo means “anew” or “from the beginning”—it is a random genetic change that happens by chance in the sperm or egg cell before conception, or very early in the development of the embryo [1]. In the remaining 10% or fewer of cases, the deletion is inherited from a parent who also has the condition [1].
Because the symptoms of 22q11.2 deletion syndrome can vary dramatically from one person to another, an adult might carry the genetic deletion with such mild symptoms that they never knew they had it until their child was diagnosed [2][3]. This is why genetic testing of both parents is an important step when a child receives a diagnosis [4]. It also means that if you are diagnosed as an adult, testing may be recommended for your parents, siblings, or existing children to see if the deletion is present elsewhere in your family [4].
Chances of Passing the Syndrome to Your Children
Whether you are an adult who has just been diagnosed, or a parent wondering about the risks for your next pregnancy, the chances of the syndrome occurring in future children depend entirely on whether you or your partner carry the deletion.
- If neither parent has the deletion: The chance of having another child with the syndrome is very low, typically estimated at around 1% [1]. This small residual risk exists due to a rare phenomenon called germline mosaicism, where a parent might have the genetic deletion only in some of their egg or sperm cells, but not in the blood cells that were tested. For all practical purposes, the recurrence risk is extremely low [1].
- If one parent has the deletion: There is a 50% chance in every pregnancy that the baby will inherit the syndrome [1]. It is also important to understand that the severity of the syndrome cannot be predicted by how it affects the parent. A parent with very mild symptoms can pass the deletion to a child who may face much more severe medical or developmental challenges [2][3].
Grappling with a 50% risk and unpredictable severity can be a heavy emotional burden. The uncertainty of how a child might be affected makes family planning a deeply personal and sometimes difficult process.
Planning for the Future
Because family planning and recurrence risks are major concerns, working with a genetic counselor is highly recommended [5][4]. A genetic counselor can help arrange chromosomal testing for you and your partner. Chromosomal Microarray (CMA) is typically the most comprehensive diagnostic test used, while FISH testing might be used for targeted checks if the specific deletion is already known in the family.
A counselor can also explain your specific risks and discuss options for future pregnancies. This includes going over prenatal testing choices, such as chorionic villus sampling (CVS) or amniocentesis, which can test for the deletion during pregnancy if you choose to explore them. Joining a patient advocacy group, such as the 22q Family Foundation, can also provide you with emotional support and community resources as you navigate these decisions.
Common questions in this guide
Is 22q11.2 deletion syndrome passed down from parents?
What are the chances of having another child with 22q11.2 deletion syndrome?
Can a parent have 22q11.2 deletion syndrome and not know it?
What genetic tests are used to check parents for the 22q11.2 deletion?
Can you test for 22q11.2 deletion syndrome during pregnancy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific genetic test (such as a microarray or FISH) should my partner and I, or other family members, undergo to check for the deletion?
- 2.If our tests come back negative, do we still need to speak with a genetic counselor before having another child?
- 3.What prenatal testing options, such as CVS or amniocentesis, would be available to us in future pregnancies to check for this syndrome?
- 4.Can you refer us to a genetic counselor to discuss our specific recurrence risks and family planning options?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (5)
- 1
Independent de novo 22q11.2 deletions in first cousins with DiGeorge/velocardiofacial syndrome.
Saitta SC, Harris SE, McDonald-McGinn DM, et al.
American journal of medical genetics. Part A 2004; (124A(3)):313-7 doi:10.1002/ajmg.a.20421.
PMID: 14708107 - 2
The 22q11.2 deletion syndrome: Genetic mechanisms, clinical manifestations, and therapeutic strategies.
Yang S, Zhuang Y, Xin S, et al.
Clinica chimica acta; international journal of clinical chemistry 2026; (586()):120893 doi:10.1016/j.cca.2026.120893.
PMID: 41690495 - 3
Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).
Kuo CY, Signer R, Saitta SC
Current allergy and asthma reports 2018; (18(12)):75 doi:10.1007/s11882-018-0823-5.
PMID: 30377837 - 4
Different Diagnoses, Common Ancestry: 22q11.2 Deletion Syndrome and Wiskott-Aldrich Syndrome in the Same Family.
Bobreshova A, Efimova I, Mukhina A, et al.
Molecular syndromology 2026; doi:10.1159/000550498.
PMID: 41768875 - 5
Consequences of 22q11.2 Microdeletion on the Genome, Individual and Population Levels.
Karbarz M
Genes 2020; (11(9)) doi:10.3390/genes11090977.
PMID: 32842603
This page explains the genetic inheritance of 22q11.2 deletion syndrome for educational purposes. A genetic counselor or medical geneticist is the best source for evaluating your family's specific recurrence risks.
Get notified when new evidence is published on 22q11.2 deletion syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.